YUNNAN BAIYAO GROUP CO.,LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 57.43 CNY | +0.31% |
|
+2.55% | +16.85% |
ETFs positioned on Yunnan Baiyao Group Co.,Ltd
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.68% | 2 M€ | -12.62% | - | |
| 1.32% | 2 M€ | -14.14% | ||
| 1.18% | 4 M€ | -2.96% | ||
| 0.13% | 35 M€ | -5.85% | - | |
| 0.11% | 3 M€ | +4.96% | - | |
| 0.10% | 4 M€ | -11.56% | ||
| 0.05% | 11 M€ | +4.66% | ||
| 0.01% | 4 M€ | -4.41% | - | |
| 0.01% | 2,808 M€ | +8.54% | - | |
| 0.01% | 149 M€ | +5.36% | - | |
| 0.01% | 441 M€ | +7.05% | - | |
| 0.01% | 117 M€ | +3.12% | - | |
| 0.00% | 31 M€ | +5.93% | - | |
| 0.00% | 7 M€ | +4.13% | - | |
| 0.00% | 34 M€ | +3.34% | - | |
| 0.00% | 34 M€ | +6.71% | - | |
| 0.00% | 389 M€ | +7.96% | - | |
| 0.00% | 39 M€ | +4.81% | - | |
| 0.00% | 302 M€ | +5.32% | - |
Yunnan Baiyao Group Co., Ltd. specializes in the development, manufacturing and marketing of pharmaceutical products. The group proposes primarily traditional medicine products, phytobiological products, body care products, antibiotics and anti-inflammatory.
China accounts for 98.9% of net sales.
Sector
Pharmaceuticals
Calendar
2024-08-28
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
57.43
CNY
Average target price
64.08
CNY
Spread / Average Target
+11.58%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +16.85% | 14.11B | |
| +31.52% | 662B | |
| +21.96% | 546B | |
| -5.21% | 359B | |
| +17.02% | 323B | |
| +5.01% | 289B | |
| +13.68% | 234B | |
| +3.81% | 198B | |
| -10.63% | 194B | |
| +3.98% | 167B |
- Stock Market
- Equities
- 000538 Stock
- Funds and ETFs Yunnan Baiyao Group Co.,Ltd